Asunto(s)
Transfusión de Sangre Autóloga , Sangre/efectos de la radiación , Terapia por Láser , Infarto del Miocardio/radioterapia , Oxígeno/sangre , Terapia Ultravioleta , Adulto , Transporte Biológico/efectos de la radiación , Humanos , Masculino , Persona de Mediana Edad , Infarto del Miocardio/sangre , Factores de TiempoRESUMEN
In addition to a complex of treatment measures, 51 patients with unstable angina pectoris received quantum hemotherapy--laser and ultraviolet blood irradiation. The control group was made up of 18 patients given pharmacological agents. The treatment efficacy was judged from the decrease of the frequency, duration and depth of painful and painless myocardial ischemia, the rate of ventricular and supraventricular premature heart beat in accordance with the data of Holter's monitoring and the rise of exercise tolerance by the bicycle ergometry data. It has been established that quantum hemotherapy raises the treatment efficacy in patients resistant to the conventional pharmacological therapy. The anti-ischemic and antianginal action was found to be more remarkable in laser blood irradiation. The antiarrhythmic action of both modalities manifests in curtailment of high grades premature heart beats.
Asunto(s)
Angina Inestable/terapia , Transfusión de Sangre Autóloga , Sangre/efectos de la radiación , Electrocardiografía Ambulatoria , Terapia por Láser , Terapia Ultravioleta , Adulto , Anciano , Angina Inestable/diagnóstico , Terapia Combinada , Estudios de Evaluación como Asunto , Prueba de Esfuerzo , Humanos , Masculino , Persona de Mediana EdadAsunto(s)
Transfusión de Sangre Autóloga , Sangre/efectos de la radiación , Enfermedad Coronaria/terapia , Terapia Ultravioleta , Enfermedad Aguda , Adulto , Anciano , Complejos Cardíacos Prematuros/epidemiología , Complejos Cardíacos Prematuros/etiología , Complejos Cardíacos Prematuros/prevención & control , Terapia Combinada , Enfermedad Coronaria/complicaciones , Estudios de Evaluación como Asunto , Humanos , Incidencia , Masculino , Persona de Mediana Edad , Infarto del Miocardio/complicaciones , Infarto del Miocardio/terapiaRESUMEN
A total of 119 patients with myocardial infarction hospitalized within 24 hrs from the disease onset were examined. He-Ne laser irradiation of the blood (daily 40 min sessions for 3-5 days) was carried out in 45 patients (Group 1). The rest 74 patients (Group 2) were administered common therapy. A number of biologically active substances were radioimmunoassayed in the blood of 12 Group 1 and 11 Group 2 patients on days 1, 3, and 7 of the disease. The pain syndrome was alleviated in Group 1 patients, in contrast to Group 2 patients, and the frequencies of ventricular arrhythmias, of heart failures, and of the condition recurrences were reduced, as was the mortality rate. Laser therapy resulted in reduction of the activities of the hypophyseoadrenocortical and aldosteron-renin-angiotensin systems. Besides blood levels of dilatants and proaggregants (PGF2 alpha, vasopressin, angiotensin II) reduced in these patients, whereas vasodilating and antiaggregation hormones (PGE, PGI2) levels increased and the PGI2/TxB2 ratio improved.